BGMA Suggests Tweaks To UK Statutory Pricing Scheme Proposals
Generics And Biosimilars Body Continues To Welcome Recognition Of Competition Impact
The BGMA has published its response to UK government proposals on the statutory scheme for branded medicine pricing • Source: Shutterstock 
